Trial
NCT04530617
Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Collaborators
—
Condition
Covid19
Intervention
Camostat Mesilate
Why stopped
Results from the interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-21